Processing equipment

New filtration tech boosts biomanufacturing yields, says Sartorius

26-Jun-2012 By Natalie Morrison

Sartorius Stedim says its new range of sterilising-grade filters can allow steam cleaning in dry conditions and minimises protein binding.

Price of water & corporate sustainability agendas pushing waste reuse; Veolia

21-Jun-2012 By Nick Taylor

The price of water and corporate agendas are driving pharmaceutical production plants to reuse and reclaim waste, Veolia said.

Freeman updates powder analysis tech

20-Jun-2012 By Natalie Morrison

Freeman Technology has added a new “intuitive” control system to its multi-purpose powder analysis system.

DSM inks antibody contract manufacturing deal for XD

19-Jun-2012

DSM has signed an antibody contract manufacturing deal focused in its intensified cell culture process, XD.

HHS investing $400m to speed pandemic vaccine production

19-Jun-2012 By Nick Taylor

HHS is investing $400m (€318m) to create centres to speed development and production of medical countermeasures.

ATMI gears up for single-use "boom" for biotech industry

18-Jun-2012 By Natalie Morrison

ATMI has added helium integrity testing of bioprocess vessels in response to what it says is a boom in the single-use technology arena.

New modulator to boost protein production, says ProBioGen

14-Jun-2012 By Natalie Morrison

ProBioGen has launched a new pathway modulator for mammalian cell lines that it says improves protein production efficiency.

New ERP causes “self-inflicted disruption” of supply at Pall

11-Jun-2012 By Nick Taylor

Pall posted weaker than expected results after the switch to a new ERP system caused “self-inflicted disruption” of supply.

Fantastic four pool together to create super suite for processing HP drugs

05-Jun-2012 By Natalie Morrison

Schenck Accurate, Malvern, PSL and Sturtevant have teamed up to create a “unique” new turnkey isolated milling suite which they say will wipe out unnecessary waiting times for high potency (HP) drug processing.

EMA posts draft guidelines on transgenic animal production

04-Jun-2012

The EMA has published draft guidelines on ensuring drug quality when producing APIs in transgenic animals.

P-Gels mean cheaper and more varied drug development, says Patheon

31-May-2012 By Natalie Morrison

Patheon says its new soft gel platform is creating cheaper development opportunities for drugsmakers.

USP replaces 'out of date' impurity testing standards

29-May-2012 By Natalie Morrison

The US Pharmacopeial Convention (USP) has introduced new elemental impurity standards to replace what it says were outdated guidelines.

The single-use age has dawned, says ThermoFisher

21-May-2012 By Natalie Morrison

Developments in single-use technology signals the end for clean-in-place biomanufacturing methods, according to ThermoFisher’s Bill Whitford.

EMD Millipore stresses ease of use and flexibility benefits of new bioreactor

21-May-2012 By Gareth Macdonald

EMD Millipore premiered a new single-use bioreactor at Interphex 2012, claiming the new design addresses industry demand for ease of use and flexibility.

Dendreon to slash costs using production automation; CFO

16-May-2012 By Nick Taylor

Dendreon hopes to cut its cost of goods sold by two-thirds through automation of tasks at its cancer vaccine plants.

in-Pharmatechnologist.com's review of Interphex 2012

10-May-2012 By Gareth Macdonald

in-Pharmatechnologist.com was at Interphex 2012 in New York, US to launch the revamped version of our website and speak to the pharmaceutical manufacturing and processing tech sector’s movers and shakers.

Fette's 'common sense' approach to boosting production

10-May-2012 By Natalie Morrison

Reduce changeover time on oral solid dose machinery by cleaning equipment offline, Fette Compacting urged drugsmakers at this year’s Interphex.

Effective controls still lacking for continuous processing says Interphex panel

09-May-2012 By Gareth Macdonald

Continuous processing is still hamstrung by a lack of control systems and is not ready for specific FDA guidance according to an industry expert panel which met at Interphex last week.

EXCLUSIVE

Single-use is the future of biomanufacturing: report from Interphex

07-May-2012 By Natalie Morrison

Advancements in single-use equipment are crucial to the development of the biotechnology industry, according to experts at this year’s Interphex.

Single-use bioprocess demand drives Sartorius’ sales jump

26-Apr-2012 By Nick Taylor

Bioprocess sales at Sartorius jumped 20 per cent in the first quarter on strong demand for single-use filters and bags.

Amgen warns biosimilar draft a threat to production innovation

25-Apr-2012 By Nick TAYLOR

Amgen has told the FDA that draft biosimilar guidance risks inhibiting manufacturing improvements and burdening industry.

in-Pharmatechnologist @ Interphex 2012

24-Apr-2012 By Gareth Macdonald

In-Pharmatechnologist.com has chosen Interphex - the drug industry’s biggest production and processing technology show – as the launch event for our new look, refocused news website.

FDA compliance IT setup needs “considerable work”, GAO says

18-Apr-2012 By Nick Taylor

The US FDA IT system for improving oversight of regulatory compliance needs “considerable work”, a GAO report found.

Bosch completes Eisai Machinery takeover

17-Apr-2012 By Gareth Macdonald

Bosch Packaging Technologies has completed the acquisition of Eisai’s machinery business, expanding its inspection technology portfolio.

EMA posts guideline to support continuous process verification

17-Apr-2012 By Nick Taylor

The EMA has released draft continuous process verification guidelines to bring its policies in line with ICH Q8, Q9 and Q10.

EMA extends real-time release testing role in new guidelines

16-Apr-2012 By Nick Taylor

The EMA has released guidelines extending use of real-time release testing (RTRT) beyond terminally sterilised products.

FDA posts media fill guidance to help PET drug manufacturers

11-Apr-2012 By Nick Taylor

The US FDA has posted guidance to help PET drug manufacturers comply with media fill rules ahead of a clampdown in June.

update

GE teams with Refine Technologies on bioprocessing integration

10-Apr-2012 By Gareth Macdonald

A new filtration cartridge supply deal between GE Healthcare and Refine Technologies is a further indication of Biopharma’s desire for greater connectivity between processing techs.

Teva to sell Quebec plant and transfer 150 staff to US CMO

29-Mar-2012

Teva is to sell its Quebec, Canada manufacturing facility and transfer 150 employees to US CMO Halo Pharmaceuticals.

Novasep to invest in purification-based manufacturing; opens China plant

27-Mar-2012 By Gareth Macdonald

Novasep says it may invest in active pharmaceutical ingredients (API) bioproduction and purification technology citing growing industry demand.

GSK to launch manufacturing skills apprenticeships

13-Mar-2012

GSK will launch an apprenticeship programme later this year to train young people in a range of industry disciplines, including manufacturing, R&D and supply chain management.

TGA to audit CSL after ethylene glycol contamination recall

12-Mar-2012 By Nick Taylor

The TGA will audit manufacturing processes at CSL Biotherapies after a fractured tank led to ethylene glycol contamination.

GE to buy Xcellerex in latest biomanufacturing-focused investment

08-Mar-2012 By Gareth Macdonald

GE Healthcare has announced plans to buy US production tech firm Xcellerex, continuing its efforts to build its biomanufacturing offering.

FDA posts guidance on Phase I CMC for live biotherapeutics

27-Feb-2012 By Nick Taylor

The US FDA has published final guidance on the CMC data needed to support early phase trials of live biotherapeutics.

Freeman sets up US subsidiary and plans to establish service lab

22-Feb-2012 By Gareth Macdonald

Freeman Technology says growing Pharma demand for analytical data prompted the formation of US subsidiary and it behind its plans for a new laboratory.

Aptar Pharma says new eDevices will speed up regulatory approval

21-Feb-2012 By Natalie Morrison

Aptar Pharma says its new eDevices can help companies gain quicker regulatory approval for their nasal drug products without having to re-do clinical trials.

GE Healthcare launches bioprocess training courses in Singapore

21-Feb-2012 By Gareth Macdonald

GE Healthcare has launched a new suite of bioprocess training courses in collaboration with a leading Singapore academic institution.

Trade secret changes critical to regulatory sharing, FDA says

14-Feb-2012 By Nick Taylor

The FDA has said it is critical that trade secret laws are changed to allow it to share manufacturing information with other regulators.

US act aims to end shortages by speeding post-approval changes

06-Feb-2012 By Nick Taylor

A US drug shortages act aims to make drug production more efficient by quickening review of post-approval manufacturing changes.

UPDATE

Tamil Nadu will be next manufacturing hit if makers meet WHO standards, says IDMA

06-Feb-2012 By Natalie Morrison

The Indian Drug Manufacturers Association (IDMA) plans to amp up pharma business in Tamil Nadu by helping more companies meet WHO production standards.

FDA & EMA plant approvals to cut bottlenecks at Genzyme

24-Jan-2012 By Nick Taylor

The FDA has followed the EMA in approving the Framingham, MA plant that Genzyme hopes will cut production bottlenecks.

SSB teams with Refine Technology to improve connectivity in biomanufacturing

24-Jan-2012 By Gareth Macdonald

Sartorius Stedim Biotech (SSB) says its partnership with Refine Technology will help meet demand for greater connectivity between retention devices and bioreactors and save Pharmas time and money

China wants vaccine production innovation to boost local sector

16-Jan-2012 By Nick Taylor

The Chinese government is encouraging development of new vaccine production processes in a bid to achieve self-reliance.

Accelrys moves into Pharma QA/QC with VelQuest acquisition

05-Jan-2012 By Natalie Morrison

R&D software firm Accelrys says it will speed up the pharma QA/QC process and reduce the compliance risk ten-fold through its $35m takeover of VelQuest.

Pall to buy ForteBio to build biopharma biz

22-Dec-2011 By Gareth Macdonald

Pall will buy US instrument maker ForteBio next year in a continuation of efforts to build its biomanufacturing technology offering.

GE wont say if turnkey bioplant partnership will cut prices for emerging nations

19-Dec-2011 By Gareth Macdonald

GE Healthcare wont say if its new turnkey biologics plant development service will offer Governments in emerging nations discounted rates.

GE and M+W team on plant and tech biologics production solution

14-Dec-2011 By Gareth Macdonald

GE Healthcare and M+W Group aim to capture a share of the rapidly expanding global biologics market with a new plant and manufacturing tech partnership.

ADC Bio wins development grant for new ADC production tech

13-Dec-2011 By Gareth Macdonald

ADC Biotechnology (ADC Bio) has secured a development grant for a new antibody drug conjugate (ADC) manufacturing technology that, it says, can make drug production cheaper.

Mettler Toledo says new tech will speed up API fermentation

08-Dec-2011 By Natalie Morrison

Mettler Toledo says its new dissolved oxygen (DO) measuring optical sensors can speed up the API production process and reduce maintenance costs.

Bosch lauds new extrusion and calendaring line’s API solubility benefits

07-Dec-2011 By Gareth Macdonald

Bosch Packaging Technology says melt extrusion is the answer to drug manufacturers’ active pharmaceutical ingredient (API) solubility questions.